Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03037645
Title Safety, PK, PD, and Antitumor Activity of SNS-062 in B Lymphoid Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sunesis Pharmaceuticals
Indications

lymphoplasmacytic lymphoma

mantle cell lymphoma

chronic lymphocytic leukemia

Therapies

Vecabrutinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.